They act on two different receptor systems, which is why the combination produces a synergistic effect greater than either peptide alone
Details: EAN/UPC: 3760155210279
The DECLARE, CANVAS and EMPA-REG CV outcomes trials assessing the SGLT2 inhibitors dapagliflozin (Farxiga, AstraZeneca), canagliflozin (Invokana, Janssen) and empagliflozin (Jardiance, Boehringer Ingelheim/Eli Lilly), respectively, all showed CV and renal benefit in adults with type 2 diabetes with established CVD, DeFronzo said
Well, its more complicated than that
For example, in a study published in 2012, a year after the most prescribed statin lost its patent exclusivity, researchers concluded that statin therapy which is used everyday by patients toward lowering their cholesterol reduced deaths by 40,000
If you plateau or need more aggressive results, you can switch to tirzepatide knowing the cost will increase